2viy | pdb_00002viy

From Proteopedia
Revision as of 09:02, 31 January 2008 by OCA (talk | contribs) (New page: left|200px<br /><applet load="2viy" size="350" color="white" frame="true" align="right" spinBox="true" caption="2viy, resolution 1.82Å" /> '''HUMAN BACE-1 IN COMP...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
File:2viy.jpg


2viy, resolution 1.82Å

Drag the structure with the mouse to rotate

HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(PENTYLSULFONYL)BENZAMIDE

Overview

Inhibition of the aspartyl protease BACE-1 has the potential to deliver a, disease-modifying therapy for Alzheimer's disease. Herein, is described, the lead generation effort which resulted, with the support of X-ray, crystallography, in the discovery of potent inhibitors based on a hydroxy, ethylamine (HEA) transition-state mimetic. These inhibitors were capable, of lowering amyloid production in a cell-based assay.

About this Structure

2VIY is a Single protein structure of sequence from Homo sapiens with VG3 as ligand. Active as Memapsin 2, with EC number 3.4.23.46 Known structural/functional Site: AC1. Full crystallographic information is available from OCA.

Reference

BACE-1 inhibitors Part 1: Identification of novel hydroxy ethylamines (HEAs)., Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Hawkins J, Hussain I, Macpherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O'Brien A, Redshaw S, Riddell D, Rowland P, Soleil V, Smith KJ, Stanway S, Stemp G, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G, Bioorg Med Chem Lett. 2007 Dec 15;. PMID:18171614

Page seeded by OCA on Thu Jan 31 11:02:01 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA